Davies MJ - Search Results

1

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.

Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjøth TV, Andreasen AH, Jensen CB, DeFronzo RA; NN8022-1922 Study Group. Davies MJ, et al. JAMA. 2015 Aug 18;314(7):687-99. doi: 10.1001/jama.2015.9676. JAMA. 2015. PMID: 26284720 Clinical Trial.

2

Liraglutide for type 2 diabetes mellitus.

Kela R, Khunti K, Davies MJ. Kela R, et al. Among authors: davies mj. Expert Opin Biol Ther. 2011 Jul;11(7):951-9. doi: 10.1517/14712598.2011.583641. Epub 2011 May 12. Expert Opin Biol Ther. 2011. PMID: 21563859 Review.

3

Treatment evaluation of liraglutide in type 2 diabetes.

Kela R, Davies MJ. Kela R, et al. Among authors: davies mj. Expert Opin Biol Ther. 2012 Nov;12(11):1551-6. doi: 10.1517/14712598.2012.716823. Epub 2012 Aug 16. Expert Opin Biol Ther. 2012. PMID: 22897447 Review.

4

Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies.

Edridge CL, Dunkley AJ, Bodicoat DH, Rose TC, Gray LJ, Davies MJ, Khunti K. Edridge CL, et al. Among authors: davies mj. PLoS One. 2015 Jun 10;10(6):e0126427. doi: 10.1371/journal.pone.0126427. eCollection 2015. PLoS One. 2015. PMID: 26061690 Free PMC article. Review.

5

The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis.

Potts JE, Gray LJ, Brady EM, Khunti K, Davies MJ, Bodicoat DH. Potts JE, et al. Among authors: davies mj. PLoS One. 2015 Jun 29;10(6):e0126769. doi: 10.1371/journal.pone.0126769. eCollection 2015. PLoS One. 2015. PMID: 26121478 Free PMC article. Review.

6

The efficacy and safety of canagliflozin across racial groups in patients with type 2 diabetes mellitus.

Gavin JR 3rd, Davies MJ, Davies M, Vijapurkar U, Alba M, Meininger G. Gavin JR 3rd, et al. Among authors: davies mj, davies m. Curr Med Res Opin. 2015;31(9):1693-702. doi: 10.1185/03007995.2015.1067192. Epub 2015 Sep 4. Curr Med Res Opin. 2015. PMID: 26121561 Clinical Trial.

7

Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial.

Davies MJ, Bain SC, Atkin SL, Rossing P, Scott D, Shamkhalova MS, Bosch-Traberg H, Syrén A, Umpierrez GE. Davies MJ, et al. Diabetes Care. 2016 Feb;39(2):222-30. doi: 10.2337/dc14-2883. Epub 2015 Dec 17. Diabetes Care. 2016. PMID: 26681713 Clinical Trial.

8

Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis.

Htike ZZ, Zaccardi F, Papamargaritis D, Webb DR, Khunti K, Davies MJ. Htike ZZ, et al. Among authors: davies mj. Diabetes Obes Metab. 2017 Apr;19(4):524-536. doi: 10.1111/dom.12849. Epub 2017 Feb 17. Diabetes Obes Metab. 2017. PMID: 27981757 Review.

9

Type 2 diabetes.

Chatterjee S, Khunti K, Davies MJ. Chatterjee S, et al. Among authors: davies mj. Lancet. 2017 Jun 3;389(10085):2239-2251. doi: 10.1016/S0140-6736(17)30058-2. Epub 2017 Feb 10. Lancet. 2017. PMID: 28190580 Review.

10

Effect of weight reductions on estimated kidney function: Post-hoc analysis of two randomized trials.

von Scholten BJ, Davies MJ, Persson F, Hansen TW, Madsbad S, Endahl L, Jepsen CH, Rossing P. von Scholten BJ, et al. Among authors: davies mj. J Diabetes Complications. 2017 Jul;31(7):1164-1168. doi: 10.1016/j.jdiacomp.2017.04.003. Epub 2017 Apr 11. J Diabetes Complications. 2017. PMID: 28462892 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,651 results

Search Page